Letters
ing a statin as an outpatient. We find a similar strong relationship between inpatient statin use and outcomes when we perform this type of analysis. Among patients not taking a statin as an outpatient prior to hospitalization, the odds ratio for inpatient statin use in multivariable logistic regression predicting being alive at day 30 is 2.81 (95% CI, 2.12-3.73; P < .001) and the odds ratio for inpatient statin use predicting discharge to home or inpatient rehabilitation facility is 2.02 (95% CI, 1.62.54; P < .001). It should also be noted that in the original article, we also showed the converse of this analysis: among outpatient statin users, statin cessation in the inpatient setting is strongly associated with worsened outcomes (Figures 1 and 3).1 Alexander C. Flint, MD, PhD Author Affiliation: Kaiser Permanente Redwood City, Redwood City, California. Corresponding Author: Alexander C. Flint, MD, PhD, Kaiser Permanente Redwood City, 1150 Veterans Blvd, Redwood City, CA 94025 ([email protected]). Conflict of Interest Disclosures: None reported.
1. Flint AC, Conell C, Rao VA, et al. Effect of statin use during hospitalization for intracerebral hemorrhage on mortality and discharge disposition. JAMA Neurol. 2014;71(11):1364-1371.
CORRECTION Error in Figure Legend : In the Original Investigation titled “Tracking Early Decline in Cognitive Function in Older Individuals at Risk for Alzheimer Disease Dementia: The Alzheimer’s Disease Cooperative Study Cognitive Function Instrument” published online February 23, 2015, in JAMA Neurology (doi:10.1001 /jamaneurol.2014.3375), the designations for CDR-G progressor and CDR-G stable were inadvertently transposed in the legend for Figure 1. This article was corrected online. Typographical Errors in Figure: In the Original Investigation titled “Mutation in CPT1C Associated With Pure Autosomal Dominant Spastic Paraplegia,” published online March 9, 2015, in JAMA Neurology (doi:10.1001/jamaneurol.2014.4769), typographical errors appeared in Figure 1. In panel B, c. 108C>G should have been c.109C>G and p. Arg37Cys should have been p.Arg37Cys. The first mention of c.108C>G in the caption should have been c.109C>G. This article was corrected online.
Call for Papers We are asking for papers to be submitted on the subject of Neuromodulation to appear in a theme issue on Neuromodulation to be published at the time of the American Neurological Association Satellite Symposium on “Circuits and Circuit Disorders: Approaches to Neuromodulation” on September 26, 2015, cosponsored by the Annals of Neurology and JAMA Neurology, at the 140th Annual Meeting of the American Neurological Association in Chicago, Illinois, at the Marriott Downtown Hotel. Articles on deep brain stimulation related to movement disorders, Tourette syndrome, obsessive-compulsive disease, depression, chemogenetics, and related disorders will be considered. Articles must be received by May 1, 2015, to allow time for peer review and necessary revisions, so that they may appear online in JAMA Neurology in September.
608
JAMA Neurology May 2015 Volume 72, Number 5 (Reprinted)
Copyright 2015 American Medical Association. All rights reserved.
Downloaded From: on 12/13/2017
jamaneurology.com
ing a statin as an outpatient. We find a similar strong relationship between inpatient statin use and outcomes when we perform this type of analysis. Among patients not taking a statin as an outpatient prior to hospitalization, the odds ratio for inpatient statin use in multivariable logistic regression predicting being alive at day 30 is 2.81 (95% CI, 2.12-3.73; P < .001) and the odds ratio for inpatient statin use predicting discharge to home or inpatient rehabilitation facility is 2.02 (95% CI, 1.62.54; P < .001). It should also be noted that in the original article, we also showed the converse of this analysis: among outpatient statin users, statin cessation in the inpatient setting is strongly associated with worsened outcomes (Figures 1 and 3).1 Alexander C. Flint, MD, PhD Author Affiliation: Kaiser Permanente Redwood City, Redwood City, California. Corresponding Author: Alexander C. Flint, MD, PhD, Kaiser Permanente Redwood City, 1150 Veterans Blvd, Redwood City, CA 94025 ([email protected]). Conflict of Interest Disclosures: None reported.
1. Flint AC, Conell C, Rao VA, et al. Effect of statin use during hospitalization for intracerebral hemorrhage on mortality and discharge disposition. JAMA Neurol. 2014;71(11):1364-1371.
CORRECTION Error in Figure Legend : In the Original Investigation titled “Tracking Early Decline in Cognitive Function in Older Individuals at Risk for Alzheimer Disease Dementia: The Alzheimer’s Disease Cooperative Study Cognitive Function Instrument” published online February 23, 2015, in JAMA Neurology (doi:10.1001 /jamaneurol.2014.3375), the designations for CDR-G progressor and CDR-G stable were inadvertently transposed in the legend for Figure 1. This article was corrected online. Typographical Errors in Figure: In the Original Investigation titled “Mutation in CPT1C Associated With Pure Autosomal Dominant Spastic Paraplegia,” published online March 9, 2015, in JAMA Neurology (doi:10.1001/jamaneurol.2014.4769), typographical errors appeared in Figure 1. In panel B, c. 108C>G should have been c.109C>G and p. Arg37Cys should have been p.Arg37Cys. The first mention of c.108C>G in the caption should have been c.109C>G. This article was corrected online.
Call for Papers We are asking for papers to be submitted on the subject of Neuromodulation to appear in a theme issue on Neuromodulation to be published at the time of the American Neurological Association Satellite Symposium on “Circuits and Circuit Disorders: Approaches to Neuromodulation” on September 26, 2015, cosponsored by the Annals of Neurology and JAMA Neurology, at the 140th Annual Meeting of the American Neurological Association in Chicago, Illinois, at the Marriott Downtown Hotel. Articles on deep brain stimulation related to movement disorders, Tourette syndrome, obsessive-compulsive disease, depression, chemogenetics, and related disorders will be considered. Articles must be received by May 1, 2015, to allow time for peer review and necessary revisions, so that they may appear online in JAMA Neurology in September.
608
JAMA Neurology May 2015 Volume 72, Number 5 (Reprinted)
Copyright 2015 American Medical Association. All rights reserved.
Downloaded From: on 12/13/2017
jamaneurology.com
